Aug 24, 2017
Pune, India, 24th August 2017: WiseGuyReports announced addition of new report, titled “Viral Conjunctivitis - Pipeline Review, H2 2017”.
Pune, India - August 24, 2017 /MarketersMedia/ —
Summary
Viral conjunctivitis, or pinkeye, is a common, self-limiting condition that is typically caused by adenovirus. Viral conjunctivitis is highly contagious, usually for 10-12 days from onset as long as the eyes are red. Symptoms include itchy eyes, tearing, redness, discharge and light sensitivity (with corneal involvement). Treatment includes lubricants, vasoconstrictors and antihistamines.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Viral Conjunctivitis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Viral Conjunctivitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1927006-viral-conjunctivitis-pipeline-review-h2-2017
The Viral Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 1 and 4 respectively.
Viral Conjunctivitis (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Viral Conjunctivitis (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Viral Conjunctivitis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Viral Conjunctivitis (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Viral Conjunctivitis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Viral Conjunctivitis (Ophthalmology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Viral Conjunctivitis (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Viral Conjunctivitis (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Content: Key Points
List of Tables
List of Figures
Introduction
Viral Conjunctivitis - Overview
Viral Conjunctivitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Viral Conjunctivitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Viral Conjunctivitis - Companies Involved in Therapeutics Development
Adenovir Pharma AB
NanoViricides Inc
Panoptes Pharma GesmbH
Shire Plc
Viral Conjunctivitis - Drug Profiles
APD-209 - Drug Profile
Product Description
Mechanism Of Action
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/1927006-viral-conjunctivitis-pipeline-review-h2-2017
Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +44 208 133 9349
Source URL: http://marketersmedia.com/global-viral-conjunctivitis-drugs-and-companies-pipeline-review-h2-2017/232905
For more information, please visit http://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 232905
A research team at Sejong University has found that stocks attracting greater attention from retail investors tend to generate lower returns in subsequent periods. The university said the findings were published last month in the prestigious Journal of International Financial Markets, Institutions & Money. The team was led by Lee Eun-mi, a professor at the university’s College of Business and Economics, and included doctoral students Yang Pujian and Yang Liu. The paper, titled “The Retreat of Arbitrage Capital: Attention Level and Nonlinear Order Flow Dynamics,” lists Yang Pujian as the first author, Lee as the corresponding author and Yang Liu as a co-author. The research team examined how retail investor attention affects institutional trading behavior and stock market returns. The researchers analyzed data from China’s A-share market spanning 2012 to 2024 and measured investor attention using the Search Volume Index (SVI) provided by Baidu, China’s leading search engine. The analysis found that stocks attracting greater investor attention tend to generate relatively lower retu
Hana Financial Group said Sunday it participated in the 2026 Autism Race the day before to promote public understanding of autism and foster a culture of respect and inclusion. The group has officially sponsored the annual running campaign, organized by the Autism Society of Korea, for seven consecutive years since 2020. About 100 participants, including Hana Financial Group Vice Chairman Lee Eun-hyung, employees and their families, voluntarily joined Saturday’s event, running alongside participants with autism. All registration fees paid by the group’s employees will be donated to the association to support people with autism. The campaign aims to encourage people to view differences not as barriers or grounds for discrimination, but as diversity that enriches society. “It is meaningful to join efforts to broaden understanding and respect for people with autism and build an inclusive society,” Lee said. “We will continue providing sincere attention and support so that people with autism and other members of society can grow together as respected members of our communities.” Han
Samsung Electronics Executive Chairman Lee Jae-yong visited the company’s semiconductor advanced packaging technology laboratory in Japan, Sunday, pledging to continue expanding its research workforce there and develop the lab into a global R&D hub for next-generation packaging technologies. According to Samsung Electronics, Lee visited Advanced Package Lab (APL) in Yokohama and discussed with researchers the latest developments in technologies for advanced packaging materials and processes, as well as ways to strengthen cooperation with Japan's materials, parts and equipment industries. Lee stressed the importance of securing advanced packaging technologies, as they are emerging as critical for artificial intelligence (AI) processor chips. APL was established in 2023 and held its official opening ceremony in September this year. Starting in 2024, Samsung Electronics has been investing 40 billion yen ($254 million) over five years to establish its research infrastructure in Japan and strengthen its competitiveness in advanced packaging technologies. APL specializes in developing and va
Institutional Shareholder Services (ISS) has recommended that shareholders vote in favor of appointing Lee Jae-keun as chairman of KB Financial Group. In its voting recommendations report obtained by The Korea Times, Sunday, the world's largest proxy advisory firm said "a vote for this resolution is warranted given the absence of any known issues concerning the nominee and the company's board dynamics." ISS also noted that KB Financial Group maintains good disclosure practices regarding committee meetings, voluntarily providing attendance records to help shareholders better assess directors' effectiveness and contributions. Most companies in Korea follow a disclosure template provided by the Korea Exchange that does not require companies to disclose committee meeting attendance records. As a result, it is common for companies to omit such information from regulatory filings, ISS added. The recommendation comes ahead of KB Financial Group's extraordinary shareholders' meeting on Nov. 20, when shareholders will vote on Lee's appointment as group chairman. If appointed, Lee will lead the gr
CJ Olive Young has expanded its Olive Better wellness retail platform to five locations, adding branches tailored to office workers and tourists as it seeks to make wellness products part of consumers’ everyday routines. The expansion comes nine months after the first store opened in Seoul’s Gwanghwamun area in January. The company added stores at Starfield Coex Mall in southern Seoul and in Seongsu in eastern Seoul both last month, adapting product selections and experiences to each neighborhood’s customers. The Coex store focuses on “office wellness,” targeting workers seeking convenient ways to maintain healthy habits during busy schedules. Healthy snacks and protein products occupy the front of the store, helping shoppers quickly find items suited to their needs. A Daily Routine Bar offers products for individual purchase, allowing customers to try wellness items during commutes or lunch breaks. The Seongsu store, which opened Friday, is the chain’s largest and emphasizes experiences for trend-conscious shoppers and foreign tourists. It includes Better Bar, a food and beve
A miniature keyboard presented by OpenAI CEO Sam Altman to Samsung Group executives is drawing attention, as the device is designed not for conventional typing but specifically for vibe coding using OpenAI's Codex. The gift is being seen as a glimpse into what Altman described to the executives as OpenAI's vision for the future of computer interaction. According to OpenAI and Samsung, Altman visited a Samsung Group training center in Yongin, Gyeonggi Province, Saturday and engaged in a fireside chat with more than 50 presidents of Samsung Electronics and other affiliates. During the event, Altman presented the Samsung executives with Codex Micro keyboards, designed to be used with Codex. Altman said the keyboard reflects the idea that people may no longer need a full keyboard in a world where they can interact with computers through voice commands and artificial intelligence (AI), adding that the device could also help users work with Codex more quickly. The Codex Micro Keyboard is a miniature keyboard released as the first hardware product under the OpenAI brand. Developed in collaborati
KB Kookmin Bank has secured the lead arranger role in a 12.6 trillion won ($9.45 billion) project to build artificial intelligence (AI) computing infrastructure in Korea, the lender said Sunday. Led by Brookfield, one of the world’s largest alternative asset managers, the project involves acquiring major high-performance computing equipment, including graphics processing units (GPUs), and supplying the infrastructure to Naver Cloud. The deal marks the largest syndicated loan arrangement in Korea’s history. Such loans allow multiple financial institutions to jointly finance a large-scale project. It is also the country’s first GPU financing deal — a departure from conventional project financing, which has typically centered on assets like real estate or power plants. Rather than relying on immediate returns, the structure uses anticipated long-term revenue from supplying AI computing capacity to support the project's substantial upfront investment needs. Of the 12.6 trillion won in total costs, roughly 10.7 trillion won will be raised through loans. As lead arranger, KB Kookmin Ba
HD Hyundai Robotics is working with Palantir Technologies to integrate artificial intelligence (AI), simulation and human engineers’ expertise into robot programming, aiming to cut programming costs by more than half. According to HD Hyundai Robotics on Sunday, Ahn Sung-hwan, the company's chief technology officer and vice president, outlined the collaboration during a keynote address at Palantir’s recent Sovereignty Bootcamp in New York. He presented his company’s strategy for applying physical AI and its vision for the technology. The collaboration focused on changing how human engineers can solve problems on factory floors. Under the two companies’ collaboration, AI agents analyze existing robot programs and propose improvements. The engineers can then refine what the AI comes up with using their practical experiences. Traditionally, skilled engineers have had to observe robots on-site and repeatedly adjust work sequences, movement paths and speeds. This reliance on individual experience has made the process difficult to standardize. HD Hyundai Robotics said the two companies
The Hong Kong Bar Association has warned that a proposed phased redevelopment of the High Court, which could span more than a decade, is “not workable” and risks deterring legal practitioners from joining the bench. The association, the professional body for barristers, urged the government to consider faster alternatives, such as repurposing the existing District Court building. In an exclusive interview with the South China Morning Post on Sunday, association chairman Jose-Antonio Maurellet SC...
US first lady Melania Trump is unlikely to travel to China with the president for the Asia-Pacific Economic Cooperation summit in Shenzhen this month. “First lady Melania Trump is not scheduled to attend the events in person,” her office said in response to a query about her travel plans. President Donald Trump is scheduled to visit the Philippines for this year’s Association of Southeast Asian Nations summit before travelling to the November 18-19 Apec event, where he will meet his Chinese...
In the third of a four-part Health Matters wellness series on frontier medicine in Hong Kong, Fiona Sun examines how a local start-up is testing a gene-editing therapy that could tackle a group of inherited eye diseases at their genetic source and what it will take to turn it into a treatment patients can access. For 15 years, Professor Zheng Zongli has worked to make gene-editing therapies safe enough to treat diseases with limited treatment options. His path has taken him from a PhD in medical...
L.A. voters will decide between Mayor Karen Bass and challenger Nithya Raman, with the city's future direction on the line. As the contentious race nears the finish, the candidates are in a dead heat.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.